Skip to main content
. 2020 May;8(10):631. doi: 10.21037/atm-19-4680

Figure 2.

Figure 2

PFS and OS of patients in the CTC subgroups (with 11 and 16 FU/3 mL as the cutoff threshold). (A,B) The Kaplan-Meier curve of PFS (A) and OS (B) of the entire cohort (n=98); (C,D) PFS (C) and OS (D) of the patients received >1 cycle of pemetrexed treatment (n=88). CTC, circulating tumor cell; FU, folate receptor unit; PFS, progression-free survival; OS, overall survival.